Matches in Wikidata for { <http://www.wikidata.org/entity/Q61921151> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q61921151 description "assaig clínic" @default.
- Q61921151 description "clinical trial" @default.
- Q61921151 description "clinical trial" @default.
- Q61921151 description "clinical trial" @default.
- Q61921151 description "clinical trial" @default.
- Q61921151 description "ensaio clínico" @default.
- Q61921151 description "ensayo clínico" @default.
- Q61921151 description "ensayu clínicu" @default.
- Q61921151 description "essai clinique" @default.
- Q61921151 description "klinisch onderzoek" @default.
- Q61921151 description "клінічне випробування" @default.
- Q61921151 description "临床试验" @default.
- Q61921151 name "Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer" @default.
- Q61921151 type Item @default.
- Q61921151 label "Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer" @default.
- Q61921151 prefLabel "Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast Cancer" @default.
- Q61921151 P1132 Q61921151-D58F3EBC-DEE0-4BCE-B595-EA6C6C4FB3EC @default.
- Q61921151 P1476 Q61921151-4F4FDF7C-C348-4C01-A507-9036A0425E99 @default.
- Q61921151 P17 Q61921151-B7E6D079-3861-4BDA-A2D8-543A3C1A3BE7 @default.
- Q61921151 P2899 Q61921151-A5124B5F-C030-48D3-891C-EAA4064A9BDF @default.
- Q61921151 P3098 Q61921151-3F6C14FD-2D72-4DB0-8B46-F2656492EC0B @default.
- Q61921151 P31 Q61921151-54984717-795A-474D-86BC-85A5A7C940EE @default.
- Q61921151 P4135 Q61921151-FDDF7B1F-A898-4579-9ABC-B4FC590BF46F @default.
- Q61921151 P4844 Q61921151-1D27B6E9-C42A-453E-8C82-4C99088B12D9 @default.
- Q61921151 P4844 Q61921151-857A3CF6-CB9F-40C4-8457-3A20191AF10F @default.
- Q61921151 P4844 Q61921151-E538D2D2-CDA4-44F8-BC5F-449DCD9F0CD9 @default.
- Q61921151 P580 Q61921151-7E350734-FFF7-442A-A010-A609229C80ED @default.
- Q61921151 P582 Q61921151-257D466A-13C5-4361-A34E-A9F40D55FEFC @default.
- Q61921151 P6099 Q61921151-A1B7489F-E1CE-45F5-9E6E-785B1041582C @default.
- Q61921151 P6153 Q61921151-BC928C31-70ED-4EEA-8829-3D5EF727AC8D @default.
- Q61921151 P8005 Q61921151-A26A818F-DF2F-4536-977A-380A6257CF0E @default.
- Q61921151 P8363 Q61921151-C6BAF4C2-D5D1-4072-BB21-0A0F03818DB8 @default.
- Q61921151 P859 Q61921151-C298EA38-E365-4CE8-B8EF-6D87B3ECEF7A @default.
- Q61921151 P1132 "+272" @default.
- Q61921151 P1476 "A Multicenter Randomized Comparative Study of Docetaxel Plus Epirubicin Versus Docetaxel Plus Capecitabine Combinations as First Line Treatment of Metastatic Breast Cancer" @default.
- Q61921151 P17 Q41 @default.
- Q61921151 P2899 "+19" @default.
- Q61921151 P3098 "NCT00429871" @default.
- Q61921151 P31 Q30612 @default.
- Q61921151 P4135 "+75" @default.
- Q61921151 P4844 Q420207 @default.
- Q61921151 P4844 Q420436 @default.
- Q61921151 P4844 Q425122 @default.
- Q61921151 P580 "2002-05-01T00:00:00Z" @default.
- Q61921151 P582 "2007-11-01T00:00:00Z" @default.
- Q61921151 P6099 Q42824827 @default.
- Q61921151 P6153 Q2302473 @default.
- Q61921151 P8005 Q76651189 @default.
- Q61921151 P8363 Q78089383 @default.
- Q61921151 P859 Q30268987 @default.